Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients

BACKGROUND: The expression of HER2, estrogen (ER) and progesterone (PR) receptor can change during the course of the disease in breast cancer (BC). Therefore, reassessment of these markers at the time of disease progression might help to optimize treatment decisions. In this context, characterizatio...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Cancer
Autors principals: Aktas, Bahriye, Kasimir-Bauer, Sabine, Müller, Volkmar, Janni, Wolfgang, Fehm, Tanja, Wallwiener, Diethelm, Pantel, Klaus, Tewes, Mitra
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2016
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4960681/
https://ncbi.nlm.nih.gov/pubmed/27456970
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2587-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars